歐洲生物銀行冷凍儲存設備市場:分析與預測(2024-2033)
市場調查報告書
商品編碼
1858514

歐洲生物銀行冷凍儲存設備市場:分析與預測(2024-2033)

Europe Biobanking Cold Storage Equipment Market: Analysis and Forecast, 2024-2033

出版日期: | 出版商: BIS Research | 英文 55 Pages | 商品交期: 1-5個工作天內

價格

2024 年歐洲生物銀行恆溫器市場規模為 5.914 億美元,預計到 2033 年將達到 11.436 億美元,在 2024-2033 年預測期內的複合年成長率為 7.60%。

為了促進基因組學、生物技術和製藥領域的研究,對組織、血液和DNA等生物樣本長期儲存的需求日益成長,這推動了歐洲生物銀行低溫儲存設備市場的發展。為了保持樣本完整性並符合當地法規,歐洲生物樣本庫正擴大採用低溫儲存系統、超低溫冷凍庫和先進的冷凍設備。鑑於這些設備在維持生物樣本品質方面發揮著至關重要的作用,其耗材、軟體、服務和儀器等相關產品佔據了市場的大部分佔有率。

關鍵市場統計數據
預測期 2024-2033
2024年評估 5.914億美元
2033年的預測 11.436億美元
複合年成長率 7.6%

隨著溫度監測、自動化和節能冷卻技術的進步,儲存的永續性和可靠性正在不斷提高。在歐盟「地平線歐洲」等資助計畫的支持下,該地區高度重視轉化研究和個人化療法,這推動了對高性能低溫儲存系統的強勁需求。更嚴格的生物銀行和資料保護法規(ISO 20387、GDPR)也加速了安全合規儲存基礎設施的普及。歐洲持續引領生物銀行庫創新,在研發投入、臨床試驗和基因組數據產出的推動下,為樣本保存、營運效率和低溫保存技術的永續性制定了國際標準。

市場介紹

由於生物生物銀行設施的擴展、精準醫療需求的日益成長以及基因組學和臨床研究的興起,歐洲生物銀行冷凍保存設備市場正經歷著穩步成長。遍佈歐洲的生物樣本庫已成為DNA、組織、血液和細胞株等生物樣本的重要儲存庫,以長期維持樣本的完整性。這些樣本需要先進的冷凍保存方法。這些系統,包括冷凍保存設備、自動化樣本管理系統和超低溫冷凍庫,對於維持樣本活性和支援後續研究應用至關重要。

強力的政府支持、財政扶持以及諸如「地平線歐洲」(Horizo​​​​n Europe)等旨在促進轉化研究和生物醫學創新的計劃,都在推動市場成長。德國、英國、瑞典和法國是生物樣本庫建設的領先國家。這些國家重視標準化的儲存流程和永續的低溫運輸管理。此外,傳統的生物樣本庫運作正向數位化生態系統轉型,更重視資料整合、自動化和物聯網賦能的溫度監控。對設備的需求持續成長,主要源於臨床試驗、生物標記鑑定和個人化治療的日益成長的需求。憑藉其完善的醫療保健基礎設施和監管體系,歐洲在生物樣本保存的可靠性、永續性和創新性方面持續引領行業標準,使其成為生物銀行冷凍保存技術的全球先驅。

市場區隔

細分:按地區

  • 歐洲

歐洲仍然是全球生物銀行冷凍儲存設備市場的領先地區。該地區擁有數量最多的生物樣本庫,這得益於其完善的醫療保健基礎設施、對研發的高度重視以及政府對生命科學舉措的大力支持。英國、德國、法國和荷蘭等國家是主要貢獻者,它們在精準醫療、基因組學和生物醫學研究領域投入大量資金。此外,歐洲對生物樣本庫嚴格的法規環境確保了對高品質冷凍儲存解決方案的需求,進一步推動了市場成長。眾多領先企業和研究機構的存在也鞏固了歐洲在該市場的主導地位。

歐洲生物樣本庫低溫儲存設備市場趨勢、促進因素與挑戰

市場趨勢

  • 對整合物聯網、人工智慧和雲端基礎的溫度監控的自動化智慧冷藏系統的需求不斷成長,以便進行即時樣品追蹤。
  • 提高節能永續冷卻技術的普及率,以符合歐盟綠色標準,減少碳排放和營運成本。
  • 擴大泛歐生物樣本庫網路和數據驅動型生物庫,以促進精準醫療和基因組研究。
  • 人們對用於先進細胞和基因治療研究的低溫儲存解決方案(液態氮氮基系統)的興趣日益濃厚。
  • 生物銀行實驗室資訊管理系統(LIMS)和區塊鏈技術增強了可追溯性和樣本完整性。
  • 製藥、學術和醫療機構合作,制定統一的生物銀行通訊協定和大規模研究資料庫。

市場促進因素

  • 歐盟和國家層面都有強力的資助計劃,例如「地平線歐洲」計劃,為生物銀行和轉化研究提供支持。
  • 個人化醫療、基因組學和生物標記發現的發展,推動了對大規模、高品質樣本庫的需求。
  • 臨床試驗活動增加以及基於人群的隊列研究需要長期儲存生物樣本。
  • 生物製藥研發投入的增加推動了對先進冷藏基礎設施的需求。
  • 嚴格的生物安全和品質保證標準推動了經認證的冷資料儲存系統的普及。
  • 擴大官民合作關係,促進醫療保健創新和生命科學研究。

市場挑戰

  • 先進低溫儲存系統和低溫設備的初始成本和維護成本較高;
  • 持續低溫運轉帶來的能源消耗和永續性問題。
  • 分散式生物樣本庫網路間互通性和資料整合的限制。
  • GDPR 下關於樣本所有權、同意管理和跨國資料共用的監管複雜性。
  • 生物樣本庫運作、維護和資料管理方面缺乏熟練人員。
  • 各國生物銀行程序標準化的挑戰影響了研究的可重複性和合作研究。

本報告深入剖析了生物銀行冷凍儲存設備的最新進展,包括溫度控制、自動化和雲端基礎監控系統等方面的創新。企業可以利用這些見解,發掘產品差異化機遇,開發新一代冷凍儲存解決方案,並整合最尖端科技,以滿足生物樣本庫和個人化醫療日益成長的需求。

該報告深入分析了各個地區和細分市場,使企業能夠瞄準生物樣本庫基礎設施需求快速成長的高成長地區。了解市場趨勢和區域動態將有助於企業調整行銷策略,並在高成長地區有效定位其產品,以滿足日益成長的先進冷凍保存解決方案的需求。

競爭策略:透過分析市場佔有率、主要參與企業和產業趨勢,企業可以評估競爭動態,識別市場領導,並制定策略以獲得競爭優勢,包括建立策略夥伴關係、進入新市場以及開發創新產品以滿足生物樣本庫和研究機構不斷變化的需求。

目錄

執行摘要

1. 歐洲生物銀行低溫恆溫器市場概覽

  • 市場概覽
  • 法律規範
    • 歐盟
  • 專利分析
    • 專利申請趨勢(按國家/地區分類)
    • 專利申請趨勢(按年份)
  • 歐洲生物銀行冷凍保存設備市場供應鏈/價值鏈分析
  • 市場動態概述
    • 市場促進因素
    • 市場限制
    • 市場機遇

第2章生物銀行冷凍保存設備市場(按地區分類),百萬美元,2022-2033年

  • 區域摘要
  • 歐洲
    • 區域概覽
    • 市場成長促進因素
    • 成長抑制因素

第3章 市場競爭情勢

  • 公司簡介
    • Eppendorf SE
    • Trane Technologies plc
    • Arctiko
    • Labcold

第4章調查方法

This report can be delivered in 2 working days.

Introduction to Europe Biobanking Cold Storage Equipment Market

The Europe biobanking cold storage equipment market was valued at $591.4 million in 2024 and is anticipated to reach $1,143.6 million by 2033, witnessing a CAGR of 7.60% during the forecast period 2024-2033. The growing demand for long-term preservation of biological samples, such as tissues, blood, and DNA, for enhanced research in genomics, biotechnology, and pharmaceuticals is propelling the market for biobanking cold storage equipment in Europe. To maintain sample integrity and adhere to local regulations, European biobanks are progressively implementing cryogenic storage systems, ultra-low temperature freezers, and sophisticated refrigeration units. Due to its crucial role in preserving biosample quality, equipment holds the greatest part of the market, which is divided into consumables, software, services, and equipment.

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$591.4 Million
2033 Forecast$1,143.6 Million
CAGR7.6%

Storage sustainability and dependability are being improved by technological advancements in temperature monitoring, automation, and energy-efficient refrigeration. great-performance cold storage systems are in great demand due to the region's significant emphasis on translational research and customized treatment, which is backed by EU-funded programs like Horizon Europe. Adoption of safe, compliant storage infrastructure is also being fueled by more stringent biobanking and data protection laws (ISO 20387, GDPR). Europe continues to be a major center for biobanking innovation, setting international standards for sample preservation, operational effectiveness, and sustainability in cold storage technology with rising R&D expenditures, clinical trials, and genomic data output.

Market Introduction

The market for biobanking cold storage equipment in Europe is growing steadily due to the expansion of the biobanking infrastructure, the growing need for precision medicine, and the rise in genomic and clinical research. In order to maintain sample integrity for long-term usage, biobanks around Europe are crucial repositories for biological samples such DNA, tissues, blood, and cell lines. These samples require sophisticated cold storage methods. These systems, which include cryogenic storage units, automated sample management systems, and ultra-low temperature freezers, are essential for preserving sample viability and assisting with further research applications.

Strong government backing, financial initiatives, and projects like Horizon Europe that foster translational research and biomedical innovation all contribute to the market's growth. Leading nations in the establishment of biobanks include Germany, the United Kingdom, Sweden, and France; these nations place a strong emphasis on standardized storage procedures and sustainable cold chain management. Additionally, traditional biobanking operations are becoming smart, digitalized ecosystems due to the increased emphasis on data integration, automation, and IoT-enabled temperature monitoring. The demand for equipment is still being driven by the growing need for clinical trials, biomarker identification, and personalized treatment. Europe continues to be a global pioneer in biobanking cold storage technology, setting standards for dependability, sustainability, and innovation in biosample preservation thanks to its sophisticated healthcare infrastructure and regulatory alignment.

Market Segmentation:

Segmentation: by Region

  • Europe

Europe remains the leading region in the global biobanking cold storage equipment market. The region is home to the highest number of biobanks, driven by a robust healthcare infrastructure, a strong focus on research and development, and government support for life sciences initiatives. Countries like the U.K, Germany, France, and the Netherlands are key contributors, with substantial investments in precision medicine, genomics, and biomedical research. Additionally, Europe's strict regulatory environment for biobanks ensures the demand for high-quality cold storage solutions, further boosting market growth. The presence of major players and research institutions also strengthens Europe's dominant position in the market.

Europe Biobanking Cold Storage Equipment Market Trends, Drivers and Challenges:

Market Trends

  • Growing demand for automated and smart cold storage systems integrating IoT, AI, and cloud-based temperature monitoring for real-time sample tracking.
  • Rising adoption of energy-efficient and sustainable refrigeration technologies to reduce carbon footprint and operational costs in compliance with EU green standards.
  • Expansion of integrated biobank networks and data-driven biorepositories across Europe for precision medicine and genomic research.
  • Increasing focus on cryogenic storage solutions (liquid nitrogen-based systems) for advanced cell and gene therapy research.
  • Digital transformation in biobanking, with laboratory information management systems (LIMS) and blockchain enhancing traceability and sample integrity.
  • Collaboration among pharma, academic, and healthcare institutions to create harmonized biobanking protocols and large-scale research databases.

Market Drivers

  • Strong EU and national funding programs such as Horizon Europe supporting biobanking and translational research.
  • Growth in personalized medicine, genomics, and biomarker discovery, driving the need for large, high-quality sample repositories.
  • Increasing clinical trial activities and population-based cohort studies requiring long-term biosample storage.
  • Rising biopharmaceutical R&D investments fueling demand for advanced cold storage infrastructure.
  • Stringent biosafety and quality assurance standards promoting the adoption of certified cold storage systems.
  • Expanding public-private partnerships for healthcare innovation and life sciences research.

Market Challenges

  • High initial and maintenance costs of advanced cold storage systems and cryogenic equipment.
  • Energy consumption and sustainability concerns due to continuous ultra-low temperature operations.
  • Limited interoperability and data integration across decentralized biobank networks.
  • Regulatory complexities around sample ownership, consent management, and cross-border data sharing under GDPR.
  • Shortage of skilled personnel in biobanking operations, maintenance, and data management.
  • Challenges in standardization of biobanking procedures across countries affecting reproducibility and collaboration.

How can this report add value to an organization?

Product/Innovation Strategy: This report provides valuable insights into the latest advancements in biobanking cold storage equipment, including innovations in temperature control, automation, and cloud-based monitoring systems. Organizations can use these insights to identify opportunities for product differentiation, develop next-generation cold storage solutions, and integrate cutting-edge technologies to meet the growing demands of biobanks and personalized medicine.

Growth/Marketing Strategy: The report offers detailed regional and market segment insights, enabling organizations to target high-growth, where demand for biobanking infrastructure is rapidly expanding. By understanding market trends and regional dynamics, companies can align their marketing strategies to effectively position their products in fast-growing regions, capitalizing on the increasing need for advanced cold storage solutions.

Competitive Strategy: By analyzing market share, key players, and industry trends, this report allows organizations to evaluate competitive dynamics, identify market leaders, and develop strategies to gain a competitive edge. This can include forming strategic partnerships, entering new markets, and developing innovative product offerings to meet the evolving needs of biobanks and research institutions.

Table of Contents

Executive Summary

Scope and Definition

1 Europe Biobanking Cold Storage Equipment Market: Overview

  • 1.1 Market Overview
  • 1.2 Regulatory Framework
    • 1.2.1 European Union (EU)
      • 1.2.1.1 Regulatory Requirements for Biobanking Cold Storage Equipment Intended as Medical Devices
  • 1.3 Patent Analysis
    • 1.3.1 Patent Filing Trend (by Country)
    • 1.3.2 Patent Filing Trend (by Year)
  • 1.4 Europe Biobanking Cold Storage Equipment Market, Supply/ Value Chain Analysis
  • 1.5 Market Dynamics Overview
    • 1.5.1 Market Drivers
      • 1.5.1.1 Growing Investments and Funding for Biobanks
      • 1.5.1.2 Increasing R&D Activities Using Biospecimens in Precision Medicine
      • 1.5.1.3 Technological Advancements and Automation in Biobanking
      • 1.5.1.4 Increasing Trend in Preservation of Cord Blood Stem Cells from Newborns
    • 1.5.2 Market Restraints
      • 1.5.2.1 Elevated Operational Costs for Biobanks
      • 1.5.2.2 High Legal and Ethical Challenges
    • 1.5.3 Market Opportunities
      • 1.5.3.1 Emerging Economies to Provide Lucrative Opportunities

2 Biobanking Cold Storage Equipment Market (By Region), $Million, 2022-2033

  • 2.1 Regional Summary
  • 2.2 Europe
    • 2.2.1 Regional Overview
    • 2.2.2 Driving Factors for Market Growth
    • 2.2.3 Factors Challenging the Market
      • 2.2.3.1 U.K.
      • 2.2.3.2 Germany
      • 2.2.3.3 France
      • 2.2.3.4 Italy
      • 2.2.3.5 Spain
      • 2.2.3.6 Rest-of-Europe

3 Markets - Competitive Landscape

  • 3.1 Company Profiles
    • 3.1.1 Eppendorf SE
      • 3.1.1.1 Overview
      • 3.1.1.2 Top Products Offered
      • 3.1.1.3 Top Competitors
      • 3.1.1.4 Target Customers/End Users
      • 3.1.1.5 Analyst View
    • 3.1.2 Trane Technologies plc
      • 3.1.2.1 Overview
      • 3.1.2.2 Top Product Offered
      • 3.1.2.3 Top Competitors
      • 3.1.2.4 Target Customers/End Users
      • 3.1.2.5 Analyst View
    • 3.1.3 Arctiko
      • 3.1.3.1 Overview
      • 3.1.3.2 Top Products Offered
      • 3.1.3.3 Top Competitors
      • 3.1.3.4 Target Customers/End Users
      • 3.1.3.5 Analyst View
    • 3.1.4 Labcold
      • 3.1.4.1 Overview
      • 3.1.4.2 Top Products Offered
      • 3.1.4.3 Top Competitors
      • 3.1.4.4 Target Customers/End Users
      • 3.1.4.5 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Europe Biobanking Cold Storage Equipment Market, $Million, 2024, 2028, and 2033
  • Figure 2: Biobanking Cold Storage Equipment Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 3: Number of Patents in Biobanking Cold Storage Equipment Market (by Country), January 2019-May 2024
  • Figure 4: Number of Patent in Biobanking Cold Storage Equipment Market (by Year), January 2011-December 2024
  • Figure 5: Supply/ Value Chain Analysis: Europe Biobanking Cold Storage Equipment Market
  • Figure 6: Legal and Ethical Challenges in Biobanking
  • Figure 7: U.K. Biobanking Cold Storage Equipment Market, $Million, 2022-2033
  • Figure 8: Germany Biobanking Cold Storage Equipment Market, $Million, 2022-2033
  • Figure 9: France Biobanking Cold Storage Equipment Market, $Million, 2022-2033
  • Figure 10: Italy Biobanking Cold Storage Equipment Market, $Million, 2022-2033
  • Figure 11: Spain biobanking cold storage equipment Market, $Million, 2022-2023
  • Figure 12: Rest of Europe Biobanking Cold Storage Equipment Market, $Million, 2022-2033
  • Figure 13: Data Triangulation
  • Figure 14: Top-Down and Bottom-Up Approach
  • Figure 15: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Europe Biobanking Cold Storage Equipment Market Opportunities
  • Table 3: Impact Analysis of Market Navigating Factors, 2022-2033
  • Table 4: Operational and Direct Labor Costs
  • Table 5: Biobanking Cold Storage Equipment Market (by Region), $Million, 2022-2033
  • Table 6: BBMRI-ERIC Biobanking Projects and Grants Across Europe
  • Table 7: Europe Biobanking Cold Storage Equipment Market (by Country), $Million, 2022-2033